PmRab7 is a VP28-binding protein involved in white spot syndrome virus infection in shrimp

Kallaya Sritunyalucksana1, Wanphen Wannapapho, Chu Fang Lo

  • 1National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathumthani 12120, Thailand.

Journal of Virology
|October 17, 2006
PubMed

Insights

Researchers identified Penaeus monodon Rab7 (PmRab7), a shrimp protein that binds to White Spot Syndrome Virus (WSSV). This discovery offers insights into WSSV infection mechanisms and potential antiviral strategies in shrimp farming.

Area of Science:

  • Aquatic animal health
  • Virology
  • Molecular biology

Background:

  • White Spot Syndrome Virus (WSSV) is a major pathogen causing significant losses in shrimp aquaculture worldwide.
  • Understanding the molecular interactions between WSSV and its host is crucial for developing effective control strategies.

Purpose of the Study:

  • To isolate and characterize shrimp proteins that bind to WSSV.
  • To investigate the role of these binding proteins in WSSV infection.

Main Methods:

  • Proteomic analysis (liquid chromatography-tandem mass spectrometry) of shrimp hemocyte membrane proteins.
  • Biochemical assays (glutathione S-transferase pull-down) to confirm protein-protein interactions.
  • Gene expression analysis (RT-PCR, real-time PCR).
  • In vivo neutralization assays and histopathology.

Main Results:

  • A 25-kDa shrimp protein, Penaeus monodon Rab7 (PmRab7), was identified as binding to the WSSV envelope protein rVP28 and WSSV itself.
  • PmRab7 expression was detected in various shrimp tissues.
  • PmRab7 binding to WSSV was dose-dependent and could be inhibited by anti-Rab7 antibody.
  • In vivo, PmRab7 or anti-Rab7 antibody significantly reduced shrimp mortality and prevented WSSV-induced histopathology.

Conclusions:

  • PmRab7 is directly involved in WSSV infection in shrimp.
  • This study is the first to identify a shrimp protein that binds to a major WSSV envelope protein, highlighting PmRab7 as a potential target for antiviral interventions.